Загрузка...
Daratumumab in untreated newly diagnosed multiple myeloma
The treatment of multiple myeloma has evolved markedly in the last decade, but mortality remains high, emphasizing the need for more effective therapies. Daratumumab, a fully human monoclonal antibody targeting CD38, has shown clinical efficacy in relapsed/refractory multiple myeloma both as monothe...
Сохранить в:
| Опубликовано в: : | Ther Adv Hematol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6928545/ https://ncbi.nlm.nih.gov/pubmed/31903177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719894871 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|